| abstract |
The present invention relates to neutrality prolactin receptor antibody Mat3 and Fab, the pharmaceutical composition that contains it and in treatment or prevention by the receptor-mediated optimum imbalance of prolactin and indication as endometriosis, adenomyosis, non-hormone female contraception, benign breast disease and mastalgia, lactation suppresses, benign prostatic hyperplasis, fiber-like knurl, application in application in high short blood prolactin alopecia and the alopecia of blood prolactin and the application in the common treatment of combination hormonotherapy inhibition galactophore epithelial cell propagation and treatment and prevention antiestrogenic resistance breast cancer. the receptor-mediated signal conduction of antibody blocking prolactin of the present invention. |